Literature DB >> 30944222

Hierarchy of clinical manifestations in SAVI N153S and V154M mouse models.

Mona Motwani1, Sudesh Pawaria2, Jennifer Bernier1, Stephanie Moses2, Kate Henry3, Terry Fang3, Linda Burkly3, Ann Marshak-Rothstein2, Katherine A Fitzgerald4.   

Abstract

Studies over the past decade have revealed a central role for innate immune sensors in autoimmune and autoinflammatory diseases. cGAS, a cytosolic DNA sensor, detects both foreign and host DNA and generates a second-messenger cGAMP, which in turn binds and activates stimulator of IFN genes (STING), leading to induction of type I interferons and inflammatory cytokines. Recently, gain-of-function mutations in STING have been identified in patients with STING-associated vasculopathy with onset in infancy (SAVI). SAVI patients present with early-onset systemic inflammation and interstitial lung disease, resulting in pulmonary fibrosis and respiratory failure. Here, we describe two independent SAVI mouse models, harboring the two most common mutations found in patients. A direct comparison of these strains reveals a hierarchy of immune abnormalities, lung inflammation and fibrosis, which do not depend on either IFN-α/β receptor signaling or mixed lineage kinase domain-like pseudokinase (MLKL)-dependent necroptotic cell death pathways. Furthermore, radiation chimera experiments reveal how bone marrow from the V154M mutant mice transfer disease to the WT host, whereas the N153S does not, indicating mutation-specific disease outcomes. Moreover, using radiation chimeras we find that T cell lymphopenia depends on T cell-intrinsic expression of the SAVI mutation. Collectively, these mutant mice recapitulate many of the disease features seen in SAVI patients and highlight mutation-specific functions of STING that shed light on the heterogeneity observed in SAVI patients.

Entities:  

Keywords:  SAVI; STING; T cells; cell death; type I interferonopathies

Year:  2019        PMID: 30944222      PMCID: PMC6475399          DOI: 10.1073/pnas.1818281116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease.

Authors:  Alevtina Gall; Piper Treuting; Keith B Elkon; Yueh-Ming Loo; Michael Gale; Glen N Barber; Daniel B Stetson
Journal:  Immunity       Date:  2012-01-27       Impact factor: 31.745

2.  Requirement of CD4-positive T cells for cellular recruitment to the lungs of mice in response to a particulate intratracheal antigen.

Authors:  J L Curtis; P K Byrd; M L Warnock; H B Kaltreider
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

3.  The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism.

Authors:  James M Murphy; Peter E Czabotar; Joanne M Hildebrand; Isabelle S Lucet; Jian-Guo Zhang; Silvia Alvarez-Diaz; Rowena Lewis; Najoua Lalaoui; Donald Metcalf; Andrew I Webb; Samuel N Young; Leila N Varghese; Gillian M Tannahill; Esme C Hatchell; Ian J Majewski; Toru Okamoto; Renwick C J Dobson; Douglas J Hilton; Jeffrey J Babon; Nicos A Nicola; Andreas Strasser; John Silke; Warren S Alexander
Journal:  Immunity       Date:  2013-09-05       Impact factor: 31.745

4.  Activated STING in a vascular and pulmonary syndrome.

Authors:  Y Liu; A A Jesus; B Marrero; Z Deng; M Boehm; A S Paller; D Yang; S E Ramsey; G A Montealegre Sanchez; K Tenbrock; H Wittkowski; O Y Jones; H S Kuehn; C-C R Lee; M A DiMattia; E W Cowen; B Gonzalez; I Palmer; J J DiGiovanna; A Biancotto; H Kim; W L Tsai; A M Trier; Y Huang; D L Stone; S Hill; H J Kim; C St Hilaire; S Gurprasad; N Plass; D Chapelle; I Horkayne-Szakaly; D Foell; A Barysenka; F Candotti; S M Holland; J D Hughes; H Mehmet; A C Issekutz; M Raffeld; J McElwee; J R Fontana; C P Minniti; S Moir; D L Kastner; M Gadina; A C Steven; P T Wingfield; S R Brooks; S D Rosenzweig; T A Fleisher; R Goldbach-Mansky
Journal:  N Engl J Med       Date:  2014-07-16       Impact factor: 91.245

5.  Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA.

Authors:  Hideyuki Yoshida; Yasutaka Okabe; Kohki Kawane; Hidehiro Fukuyama; Shigekazu Nagata
Journal:  Nat Immunol       Date:  2004-11-28       Impact factor: 25.606

6.  Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction.

Authors:  M Sato; H Suemori; N Hata; M Asagiri; K Ogasawara; K Nakao; T Nakaya; M Katsuki; S Noguchi; N Tanaka; T Taniguchi
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

7.  Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid.

Authors:  Joseph Conlon; Dara L Burdette; Shruti Sharma; Numana Bhat; Mikayla Thompson; Zhaozhao Jiang; Vijay A K Rathinam; Brian Monks; Tengchuan Jin; T Sam Xiao; Stefanie N Vogel; Russell E Vance; Katherine A Fitzgerald
Journal:  J Immunol       Date:  2013-04-12       Impact factor: 5.422

8.  IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway.

Authors:  Katherine A Fitzgerald; Sarah M McWhirter; Kerrie L Faia; Daniel C Rowe; Eicke Latz; Douglas T Golenbock; Anthony J Coyle; Sha-Mei Liao; Tom Maniatis
Journal:  Nat Immunol       Date:  2003-05       Impact factor: 25.606

9.  Trex1 prevents cell-intrinsic initiation of autoimmunity.

Authors:  Daniel B Stetson; Joan S Ko; Thierry Heidmann; Ruslan Medzhitov
Journal:  Cell       Date:  2008-08-22       Impact factor: 41.582

10.  Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection.

Authors:  Ganesh A Kolumam; Sunil Thomas; Lucas J Thompson; Jonathan Sprent; Kaja Murali-Krishna
Journal:  J Exp Med       Date:  2005-08-29       Impact factor: 14.307

View more
  30 in total

1.  STING Gain-of-Function Disrupts Lymph Node Organogenesis and Innate Lymphoid Cell Development in Mice.

Authors:  Brock G Bennion; Carys A Croft; Teresa L Ai; Wei Qian; Amber M Menos; Cathrine A Miner; Marie-Louis Frémond; Jean-Marc Doisne; Prabhakar S Andhey; Derek J Platt; Jennifer K Bando; Erin R Wang; Hella Luksch; Thierry J Molina; Elisha D O Roberson; Maxim N Artyomov; Angela Rösen-Wolff; Marco Colonna; Frédéric Rieux-Laucat; James P Di Santo; Bénédicte Neven; Jonathan J Miner
Journal:  Cell Rep       Date:  2020-06-16       Impact factor: 9.423

2.  Role of Interferon-γ-Producing Th1 Cells in a Murine Model of Type I Interferon-Independent Autoinflammation Resulting From DNase II Deficiency.

Authors:  Sudesh Pawaria; Kerstin Nündel; Kevin M Gao; Stephanie Moses; Patricia Busto; Kevin Holt; Rohit B Sharma; Michael A Brehm; Ellen M Gravallese; Merav Socolovsky; Anette Christ; Ann Marshak-Rothstein
Journal:  Arthritis Rheumatol       Date:  2019-12-29       Impact factor: 10.995

3.  Interferon-Independent Activities of Mammalian STING Mediate Antiviral Response and Tumor Immune Evasion.

Authors:  Jianjun Wu; Nicole Dobbs; Kun Yang; Nan Yan
Journal:  Immunity       Date:  2020-07-07       Impact factor: 31.745

Review 4.  Pathogenic insights from genetic causes of autoinflammatory inflammasomopathies and interferonopathies.

Authors:  Bin Lin; Raphaela Goldbach-Mansky
Journal:  J Allergy Clin Immunol       Date:  2021-12-08       Impact factor: 10.793

Review 5.  No Longer A One-Trick Pony: STING Signaling Activity Beyond Interferon.

Authors:  Jianjun Wu; Nan Yan
Journal:  J Mol Biol       Date:  2021-10-08       Impact factor: 5.469

Review 6.  Animal Models for the Study of Nucleic Acid Immunity: Novel Tools and New Perspectives.

Authors:  Isabelle K Vila; Maxence Fretaud; Dimitrios Vlachakis; Nadine Laguette; Christelle Langevin
Journal:  J Mol Biol       Date:  2020-08-26       Impact factor: 5.469

Review 7.  The Role of Cutaneous Type I IFNs in Autoimmune and Autoinflammatory Diseases.

Authors:  Jessica L Turnier; J Michelle Kahlenberg
Journal:  J Immunol       Date:  2020-12-01       Impact factor: 5.422

8.  Tonic prime-boost of STING signalling mediates Niemann-Pick disease type C.

Authors:  Ting-Ting Chu; Xintao Tu; Kun Yang; Jianjun Wu; Joyce J Repa; Nan Yan
Journal:  Nature       Date:  2021-07-21       Impact factor: 49.962

Review 9.  The cGAS-STING pathway: The role of self-DNA sensing in inflammatory lung disease.

Authors:  Ruihua Ma; Tatiana P Ortiz Serrano; Jennifer Davis; Andrew D Prigge; Karen M Ridge
Journal:  FASEB J       Date:  2020-08-28       Impact factor: 5.191

10.  STING inhibitors target the cyclic dinucleotide binding pocket.

Authors:  Ze Hong; Jiahao Mei; Chenhui Li; Guohui Bai; Munire Maimaiti; Haiyang Hu; Wenying Yu; Li Sun; Lele Zhang; Dan Cheng; Yixian Liao; Senlin Li; Yanping You; Hongbin Sun; Jing Huang; Xing Liu; Judy Lieberman; Chen Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.